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Serum  complement is  of potential importance to  clinical medicine and to 
human  biology in  immune  reactions  and  hypersensitivity states.  However, 
most studies on the  characteristics and mechanism of action of complement 
have been performed on systems largely of non-human origin (1, 2). The present 
studies were undertaken to study a specific immune human hemolytic disorder 
and to use this as a  model system for the  study of human complement in a 
reaction  system involving human  erythrocytes and  an  antibody of  human 
origin. The Donath-Landsteiner (D-L) reaction (3), responsible for the clinical 
syndrome of paroxysmal cold hemoglobinuria, is a reaction which requires for 
hemolysis  that  erythrocytes  be  incubated  with  antibody  and  fresh  serum 
complement first at low temperatures, usually near 0°C., and then at higher 
temperatures, usually 37°C.  It was chosen as the model for these studies be- 
cause: (a) it involves human ceils and antibody and avoids the use of reagents 
from multiple species  (rabbit  antibody,  sheep  red  cells,  guinea pig  comple- 
ment); (b)  the D-L antibody is an active hemolysin but a weak agglutinin in 
contrast to the isoantibodies and cold agglutinins; and (c) the biphasic nature 
of the reaction permits the separation of the early and late phases of comple- 
ment action. 
The studies in the present paper were undertaken to define the kinetics of 
the Donath-Landsteiner reaction and served as the basis for the observations 
on the mechanism of action of complement in the succeeding paper. The data 
indicate that many conflicting earlier observations regarding the role of com- 
plement in the reaction (3--8) may be explained on the basis of variation in 
(a) potency and amount of antibody used, (b) sensitivity of cells,  (c) amount 
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and  species  source  of  serum  complement,  and  (d)  kinetic  conditions  such  as 
temperature,  pH,  and  ionic  environment.  The  subsequent  paper  describes 
observations  on  the  mechanism  of  action  of  complement,  in  particular  the 
role of the first component  of complement  (Cq)  and the esterase derived from 
it  (Cq  esterase)  in  initiating  immune  human  hemolysis. 
MATERIALS  AND  METHODS 
Donath-Landsteiner Antibody.--Serum  was  obtained from  two patients with  paroxysmal 
cold hemoglobinuria. 
Case I was a 54 year old white male who was admitted to Cleveland Metropolitan General 
Hospital in December, 1958, because of paroxysms of hemoglobinuria following cold exposure 
and symptoms suggestive of paresis. Serologic tests for syphilis (Kline)  in blood and spinal 
fluid were strongly positive, and the Donath-Landsteiner test was positive. Cold agglutinins 
were present in a titer of 1 to 4. 
Case II was a  32 year old Negro woman who had paroxysmal cold hemoglobinuria, but 
who had no history or stigmata of  luetic infection.  Her blood serology was  negative. The 
D-L reaction was positive. The patient had no Raynaud's-like phenomena, and cold aggtu- 
tinins were weakly  positive at  a  fiter of  1 to  8.  Characteristics of the antibody from  this 
patient have been described briefly by Schmidt and Clifford (9). 
Purification of Antibody.--(a)  Alcohol fractionation: To obtain the D-L hemolysin free of 
the components of complement, gamma-2 globulin was prepared by ethanol fractionation of 
the serum of case I, according to the method of Deutsch and coworkers (10). Following the 
final precipitation the purified material was dissolved in barbital buffer containing 5  X  10  -~ 
Mg  ++ and 1.5 X  10  -4, M Ca  ++, at pH 7.4 and ionic strength 0.15,  unless otherwise noted. 
Two preparations contained 1.0 and 1.2 mg. protein N/ml. and represented approximately a 
fourfold purification with respect to serum. They contained no detectable amounts of any of 
the  four  components of  serum  complement.  These  preparations were  designated "purified 
antibody I." The Kline test was negative on one and weakly positive on the other of the two 
preparations of the undiluted purified material, but was strongly positive on the untreated 
serum at a 1 to 10 dilution. The hemolytic antibody activity of serum and purified preparations 
was stable to heating at 56°C. for 30 minutes. At least half the original D-L antibody activity 
remained in the residual material from fraction II +  III after the gamma-2 fraction was re- 
moved. This material had the same quantitative reaction in the Kline test as original serum. 
(b)  Column  chromatography:  Other  preparations  of  partially  purified  antibody  were 
obtained by chromatographic separation of serum from cases  I  and II on  DEAE  ce]lulose 
columns  (Brown  &  Co.,  Berlin,  New  Hampshire,  selectacel)  according  to  the  method  de- 
scribed by Fahey et al.  (11).  Fractions were concentrated by lyophilization  or ultrafiltration 
dialysis. Virtually all the activity was recovered in the fraction eluted  with pH 8.0,  0.01  M 
Fhosphate buffer, which migrated on paper electrophoresis as gamma globulin. These prepara- 
tions were designated "column-fractionated antibody I  or II." 
Treatment of Serum Containing Antibody to Inactivate the Components of Complement (Com- 
plement-Depleted Antiserum).--Parts  of  these  studies  were  performed  with  unfractionated 
antiserum. For this purpose serum from cases I  and II was incubated at 37°C.  for 60 minutes 
with 2 mg./ml, of zymosan (Fleischmann No.  7B152)  (12)  to inactivate C'3, the third com- 
ponent of complement.  After centrifugation to  remove zymosan,  the serum  was incubated 
for 60 minutes at 37°C.  with 0.25 ml. of 0.15  za NH3 per ml. of serum to inactivate C'4,  the 
fourth component of complement; 0.25 ml. of 0.15 za HC1 per ml. of serum was then added to 
neutralize the NH3,  and the serum was heated at 56°C.  for 3(1 minutes to inactivate C'I and 
C%  the first and  second  components of  complement  (13).  The  final dilution was  1 to  1.5 
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complement, as measured by the dilution titration technique (13,  14),  and  therefore were 
considered adequate for use in studies on the role of complement in the D-L reaction. The 
treated sera from cases I  and II were designated complement-depleted  antiserum I  or II and 
contained D-L antibody activity equal to the original serum when tested with added fresh 
normal human serum as a source of complement. 
Cold agglutinins in the sera containing D-L antibody were determined by incubating 0.2 
ml. volumes of serial twofold dilutions of antiserum in barbital buffer containing 1.5  X  10-  4 
Ca  ++ and 5 X  10  -4 M Mg++ with 0.2 ml. of a 2 per cent suspension of normal group O eryth- 
rocytes in the same barbital buffer at room temperature for 1 hour and then overnight in a 
refrigerator at  5°C.  Upon  removal from  the  refrigerator the  degree of agglutination  was 
determined macroscopically by disruption of the cell button by gentle inversion. The titer 
was the highest dilution of antiserum causing any agglutination. 
Erythrocytes.--Erythrocytes were obtained from a  normal person of blood group O and a 
patient with paroxysmal nocturnal hemoglobinuria (PNH), who was also of blood group  O. 
Cells from PNH patients have been used regularly (15, 16) for the study of hemolysins since 
they are more susceptible to hemolytic antibodies than are normal cells. Although the PNH 
abnormality renders the erythrocytes subject to  hemolysis by  acidified  undiluted  normal 
human serum, normal serum does not cause lysis of PNH cells at pH 7.4 and a serum dilution 
of 1 to 3, as was used in the present study (vide infra). Blood was defibrinated and centrifuged 
at room temperature to avoid adsorption of incomplete cold antibody to the cells. The packed 
unwashed cells  were stored in an equal volume of modified Alsevers (13) solution at 4°C. 
for periods less than 1 week.  Prior to use they were washed three times with 0.15 ~  NaC1, 
once with pH 7.4 barbital buffer, containing 5 X  10  -4 M Mg++ and 1.5 X  10  -4 ~  Ca++, and 
suspended to 25 per cent by volume in the same buffer, unless otherwise noted. For experi- 
ments involving alteration of pH, cells were suspended in 0.15 M NaC1. 
Serum.--Individual  human  sera, as  a  source of complement, were  obtained from  defi- 
brinated blood and were used immediately or stored at  --65°C. in a mechanical deep freeze. 
Other Reagents.--Barbital buffer, ionic strength 0.15, pH 7.4, containing 5 X  10-4 ~¢ Mg++ 
and 1.5 X  10-  4 M Ca  ++, was prepared as described previously (13, 14). Barbital buffer without 
added Mg  ++ or Ca  ++ was used in experiments on the requirement for those ions in the reaction. 
Unless otherwise designated, the term barbital buffer refers to the buffer with added ions. 
Isotonic NaCI (0.15 M) was used in place of barbital buffer in experiments when pH was varied. 
Michaelis buffer, ionic strength 0.15  at  various pH values, was used in experiments in 
which pH was altered (17). One M CaC12 and MgC12 were diluted in 0.15 ~  NaC1 for experi- 
ments involving various concentrations of Ca  ++ and Mg++. The ionic strength of reaction 
mixtures was altered by adding appropriate amounts of NaCl and distilled water prior to the 
addition of erythrocytes. 
Ethylenediamine tetra acetic acid (EDTA)  and its various salts were obtained as Seques- 
trene  ® from Geigy Chemicals Co.,  New York,  as  Na~EDTA,  Na2MgEDTA,  and  Na2Ca- 
EDTA. They were made up at 0.15 M concentrations in 0.15 ~  NaCI, and further dilutions 
were made in 0.15 M NaCl. 
Resin-treated serum was prepared by exposing serum to  an equal  volume of amberlite 
IRC-50  (Rohm and  Haas),  Na  cycle,  for  10  minutes at  4°C., followed by aspiration and 
centrifugation of the serum to remove particulate resin, and was used immediately. 
An International refrigerated centrifuge (PR-2) at 2°C. was used for centrifugation after the 
cold phase; centrifugation after the warm phase was in International table-model centrifuges 
at room temperature. 
Cold incubation was in a  refrigerated cold bath thermostatically controlled to I°C. 4- 1  °, 
or  at  various  temperatures in  Dewar  flasks.  Warm  incubation  was  in  a  thermostatically 
controlled water bath at 37°C.  4- 0.5 ° or at various temperatures in Dewar flasks. 
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Cold phase: To 10 x 100 mm. test tubes in a tray of melting ice at 5°C., in sequence were 
added 0.05  ml.  of a  25 per cent suspension of erythrocytes, 0.1  ml.  of fresh human serum, 
0.05 ml. or 0.10 ml. of an appropriate dilution of complement-depleted  antiserum or purified 
antibody, and barbital buffer to correct the final volume to 0.30 or 0.35 mL After mixing, the 
tubes were incubated at  I°C. for 30  minutes with frequent mixing by agitation; 3  ml.  of 
barbital buffer at I°C. were added; the cells were centrifuged at 1500 G for 5 minutes at 2°C. 
and washed a second time in similar fashion with 3 ml. of cold buffer.  No hemolysis occurred 
during the cold phase. 
Warm phase: Mter the second wash, the tubes containing the cell  buttons were trans- 
ferred to an ice bath, 0.1 ml. of human serum was added, and the volume was adjusted to 0.3 
ml. with barbital buffer; the tubes were mixed by agitation and incubated at 37°C.  for 30 
minutes, during which time hemolysis occurred. 
Quantitation of hemolysis: (a)  qualitative hemolysis was scored visually on a 0 to +++ 
scale,  covering a range from 0 to  approximately 50  per cent hemolysis. The nature  of the 
D-L reaction is such that complete hemolysis was not attainable under the conditions of 
these tests; (b)  quantitative determination of hemolysis was performed by diluting 0.1  ml. 
of supernatant with 0.9 ml. distilled water and reading the optical density at 540 millimicrons 
along a light path of 12 ram. in a Bausch and Lomb Spectronic 20 colorimeter. One hundred 
per cent hemolysis was equivalent to an optical density of approximately 0.70. 
When incubations were  done at  various  temperatures, the  cells  were  washed at  those 
temperatures. Incubation for various times in the cold was followed immediately by centrifu- 
gation at 2°C. 
Appropriate control tubes lacking serum or antibody were included in  each experiment. 
Under the conditions of dilution and pH in these experiments there was no hemolysis of the 
normal erythrocytes or erythrocytes from patients with paroxysmal nocturnal hemoglobinuria 
in the presence of normal human serum, but in the absence of the Donath-Landsteiner anti- 
body. Thus, as noted above, at pH 7.4 with serum complement diluted one to three, no acid 
hemolysis of PNH cells occurred. Hemolysis occurred only when D-L antibody was added. 
Effect of Concentration of Complement and Erythrocytes.--The conditions of both the cold 
and warm phase were selected on the basis of a  series  of preliminary experiments in which 
the effect of variations in the amount of complement, number of erythrocytes, and volume 
of reaction was studied. 
A fivefold increase or eightfold decrease in the amount of fresh serum in the cold phase did 
not alter the degree of hemolysis, indicating that an excess of complement was present in the 
usual experimental conditions. Increase in  the volume of the reaction mixture resulted in 
diminished hemolysis. Utilization of larger numbers of cells resulted in greater total hemolysis, 
but a decreased percentage of cells was hemolyzed. 
Conditions involving an excess of complement were chosen to be comparable to previously 
reported studies. The final selection of conditions was influenced by a limited supply of anti- 
body and by the amount of hemolysis which could be detected colorimetrically. The  system 
was usually fimiting with respect to antibody and cells, but there was excess complement, as 
noted.  Under these conditions there was almost complete utilization of antibody,  but  no 
measurable fixation  of complement during either the cold or warm phase. 
RESULTS 
I.  Influence of Antibody Potency, Erythrocyte Sensitivity,  and 
the Presence of Complement on the Donath-Landsteiner 
Reaction 
A.  Antibody  Potency  and  Erythrocyte  Sensitivity.--Serial  twofold  dilutions 
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against  normal  and  PNH  erythrocytes  when  fresh  serum  was  present  as  a 
source of complement in both the cold and warm phase of the reaction (Table 
I).  Against normal  erythrocytes,  complement-depleted  antiserum  I, from the 
luetic  patient,  caused appreciable  hemolysis  only in  the  undiluted  state  (ex- 
pressed as a  titer of 1); purified antibody I  or column-fractionated antibody I 
were only active when concentrated twofold with respect to the original serum. 
Complement-depleted  antiserum  II,  however,  caused  hemolysis  of  normal 
cells at a  dilution of 1 to 32. 
Relative 
TABLE I 
Activities  of  Several Preparations of  Donath-Landsteiner Antibody---Complement 
Present in Cold and Warm Phase 
Antibody  preparation 
Case I 
Complement-depleted antiserum I .................... 
Purified antibody I ................................. 
Column-fractionated  antibody I ...................... 
Case II 
Complement-depleted antiserum II ................... 
Column-fractionated  antibody II ..................... 
Titer of hemolytic  activity 
Normal ceHs 
1 
½ 
32 
PNH cells 
128 
64 
The titer of hemolytic activity is expressed as the reciprocal of the dilution of 0.1 ml. of 
antibody or antiserum  resulting  in optical  density  of 0.12 under  conditions  described in 
methods.  Twofold dilutions  were  made  serially,  and  end points  between  two  tubes  were 
expressed as the interpolated half dilution. When more than 0.1 ml. of antiserum was required 
to cause lysis, the volume of antiserum was increased to 0.2 ml. or a concentrated preparation 
of partially purified antibody was used. 
In contrast, the titer of hemolytic activity of all the antibody preparations 
was four to eight times higher when PNH erythrocytes were used. This greater 
sensitivity  of PNH  erythrocytes to hemolytic antibodies  is  well known (16), 
and made possible a variety of studies with purified antibody I  that would not 
have  been  possible  with  normal  cells.  These  observations  emphasize  that 
hemolysis in the D-L reaction is  a  function of both activity of the antibody 
and  sensitivity  of  the  erythrocytes. 
B.  The Requirement for Complement  During  the Cold  and  Warm Phases of 
the  Donath-Landsteiner  Reaction.--A  major  point  of  controversy  about  the 
D-L reaction has been concerned with the requirement for complement during 
the initial  cold phase of the reaction. It is agreed that complement must par- 
ticipate  at  some point  in  the  D-L reaction.  In experiments  to  be described, 
complement was omitted during the cold phase when cells and antibody were 
incubated  together,  but  was present during the subsequent warm phase.  The 
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none of the reactants was carried over from the cold to the warm phase. Using 
normal erythrocytes, none of the antibody preparations  caused more than a 
trace of warm phase hemolysis when fresh serum had been omitted in the prior 
cold phase. However, as shown in Fig.  1 using  PNH cells,  appreciable warm 
phase hemolysis occurred even when complement had been omitted in the cold 
phase, when complement depleted antiserum II was used at a dilution as great 
as 1/~. The addition of serum complement in the cold phase not only increased 
appreciably the amount of hemolysis, but also permitted lysis at much higher 
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Fzo. 1.  The effect of complement in the cold phase of the Donath-Landsteiner reaction on 
PNH erythrocytes. Various dilutions of complement-depleted  antiserum II and PNH erythro- 
cytes were incubated with or without serum complement at  I°C. for 30 minutes. Hemolysis 
was  measured  following  subsequent incubation  with  serum  complement at  37°C.  for  30 
minutes. An arithmetic plot of antibody dilutions on  the abscissa was chosen for ease of 
graphic representation. 
dilutions of antibody. Similar results were obtained with PNH cells using  the 
several antibody preparations from case I. Thus, the use of large amounts  of 
antibody permitted completion of the  cold phase  in  the  absence of  comple- 
ment; the requirement for complement in the cold phase, therefore, is a quanti- 
tative rather than a  qualitative one,  depending on potency of  antibody and 
sensitivity of erythrocytes. 
When  the  several antibodies  were incubated with  cells  in  the presence of 
excess fresh serum complement in the cold phase, washed,  and tested for the 
requirement for complement in the warm phase, similar results were observed. 
At none of the concentrations of antibody used did normal cells hemolyze in 
the  warm phase  in  the  absence of complement. However, when PNH cells, 
fresh serum, and undiluted complement-depleted antiserum II were incubated 
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absence of added complement. This was comparable in amount to the hemolysis 
caused by a ~28  dilution of the antiserum when complement was present in 
both  the  cold and  warm phases.  Similarly,  when  an  eightfold  concentrated 
preparation of column-fractioned antibody I  was incubated with fresh  serum 
and PNH cells in the cold, some hemolysis occurred even in the  absence of 
complement in the warm phase. Thus, greater amounts of antibody were  re- 
quired to cause hemolysis when complement was absent in the warm phase than 
when it was absent in the cold phase. In each instance, the degree of hemolysis 
was increased markedly when complement was added in the warm phase. 
In none of the experiments reported here was it possible to cause hemolysis 
when complement was lacking from both phases. Even using high concentra- 
tions of antibody and the sensitive PNH cells, it was necessary that fresh serum 
containing complement be present in either the cold or the warm phase of the 
reaction for lysis to occur. Data demonstrating the requirement for all of the 
components of hemolytic complement in the D-L reaction will be presented in 
the  following  paper. 
C.  Effect  of Heated Serum in the Cold Phase.--When purified D-L antibody 
was used in the cold phase of the reaction with fresh serum as the source of 
complement, the addition of heated normal serum to the reaction mixture in 
the cold inconstantly resulted in a moderate decrease in hemolysis in the sub- 
sequent  warm  phase,  even though  the  cells were  washed  and  incubated  in 
fresh serum in the warm. Thus, heated normal serum had a variable inhibitory 
effect on the cold phase of the reaction, an effect which may have been due to 
the anticomplementary properties of some heated sera. This observation may 
account for some previous reports on the apparent thermolability of the D-L 
antibody (6,  18,  19),  since heated antiserum has been frequently used as the 
source of antibody. 
H.  The Kinetics of the Hemolytic Reaction 
Observations  were  made  on  the  effects  of  time,  temperature,  pH,  ionic 
strength, and Ca  ~" and Mg  ++ on the cold and warm phases of the D-L re- 
action. In each instance these characteristics were studied using several com- 
binations of antibody and normal or PNH cells,  including (a) PNH cells and 
purified antibody I at a dilution of 1 to 2, a level requiring fresh serum in both 
the  cold and warm phases;  (b)  normal  cells and  complement-depleted anti- 
serum II at a dilution of 1 to 8, a level requiring fresh serum in both phases; 
and  (c)  PNH cells and complement-depleted antiserum II at a  dilution of  1 
to 8, a level that did not require fresh serum in the cold phase. In all the experi- 
ments,  excess  complement  was  supplied  in  both  phases  of  the  reaction  as 
described in methods.  The  term  "activation" in  the  cold phase  is  used  to 
indicate preparation of the erythrocytes for hemolysis during incubation with 
serum  in  the  subsequent  warm  phase. 184  IMMUNE  HUMAN  HEMOLYSIS.  I. 
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Fro. 2.  Effect of temperature on the cold phase of the Donath-Landsteiner reaction, using 
several antibody preparations and cell types in the presence of excess complement. 
Key:  (1)  PNH cells  and purified antibody I;  (2)  Normal cells and complement-depleted 
antiserum II; (3)  PNH cells and complement-depleted antiserum II. 
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FIG. 3.  Effect of temperature on the warm phase of the Donath-Landsteiner reaction. 
Key:  (1)  PNI-I cell and purified antibody I;  (2)  Normal cells and complement-depleted 
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A.  Effect of Temperature of Incubation. m 
Cold phase: During incubation for 30 minutes at various temperatures, there 
was a progressive increase in the activation of the cells with decreasing tem- 
perature. Maximum activation occurred when the cold phase was carried out 
at 1°C. (Fig. 2). Only with the most sensitive system involving PNH ceils and 
the  more  potent  antiserum  did  appreciable  activation  occur  above  10°C., 
again emphasizing the importance of both  antibody potency and cell  sensi- 
tivity in determining conditions under which the reaction will proceed. 
Warm phase: Following a  cold phase at 1°C. there was considerable hemol- 
ysis during subsequent incubation at temperatures as low as 10°C.  (Fig.  3). 
There was a progressive increase in the amount of hemolysis as the temperature 
was increased to 32°C.  At temperatures above 32°C.  there was a  progressive 
decrease in hemolysis. The same relative degree of sensitivity existed as was 
evident in the earlier studies; the antiserum from case II acting on PNH cells 
resulted in greater hemolysis at lower temperatures than did the others, Al- 
though the optimum appeared  to be 32°C., most subsequent reactions were 
carried out at 37°C., which was nearly optimal. 
B.  Time of Incubation.- 
Cold phase: During the cold phase at l°C. there was a rapid increase in degree 
of activation during the first 10 to 15 minutes of incubation with a relatively 
slow increase thereafter (Fig. 4). At variable times up to 60 minutes there was 
no observed diminution in the activity of the cell-antibody complex, as had 
been observed by Yorke and MacFie (18).  Longer periods of incubation were 
not attempted. In all subsequent experiments a period of 30 minutes at I°C. 
was used as a  standard period of cold incubation. 
Warm phase: Following incubation at  l°C.  for 30  minutes, hemolysis oc- 
curred rapidly during incubation in serum at 37°C.  (Fig. 5). Mter the cold 
phase, when washed cell buttons were transferred to the 37°C. bath and serum 
warmed to 37°C.  was  added,  there was  considerable hemolysis in a  sample 
obtained after 30 seconds, and hemolysis was nearly complete at the end of 1 
minute. Although there were absolute differences of degree in the amount of 
hemolysis which occurred, the rates of hemolysis were approximately the same 
in the several systems under these conditions. A 30-minute period of incubation 
at 37°C. was used in all subsequent experiments. 
C.  pH.--Alteration of pH at constant ionic strength of 0.15  was effected 
with Michaelis buffers added to serum in which the pH had been adjusted with 
0.15 ~r HC1 or NaOH. The two phases were studied separately with incubation 
in the alternate phase at pH 7.4 in barbital buffer. Reactions utilizing PNH 
ceils  and  purified  antibody  I,  and  normal  cells  with  complement-depleted 
antiserum II were studied. In both instances the hemolytic reaction was in- 
hibited at pH values below 5.2 and above 9.7 in either the cold or warm phase. 
For normal cells and complement-depleted antiserum II the optimum range 186  TMMUN'E  tt'UMAN  HEMOLYSIS.  I. 
in both the cold and warm phases was between pH 7.5 and 8.5. For PNH cells 
and purified antibody I, a broader optimum was observed in both the cold and 
warm phases with maximum activity between pH 6.0 and 8.0 in the cold phase 
and between pH 6.5 and 8.5 in the warm phase. PNH cells, which characteris- 
tically undergo hemolysis in undiluted serum at pH 7.0, were not lysed in the 
presence of normal human serum and in the absence of D-L antibody under 
the conditions of these experiments, even at pH 7.0. These data on pH optima 
are in agreement with those reported by Dacie (16). 
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FIG. 4. Effect of time of incubation during the cold phase of the  Donath-Landsteiner 
reaction. 
Key: (1) PNH cells and purified antibody I; (2) Normal cells and complement-depleted 
a.utiserum IT. 
D.  Ionic Strength.--An increase in ionic strength had a  marked inhibitory 
effect on the D-L reaction, particularly on the  two systems requiring fresh 
serum in the cold phase.  In the cold phase there was progressive decrease in 
activity  as  the  ionic  strength  was  increased,  decreasing  to  about  one-half 
activity at ionic strength 0.30. The effect was more marked in the warm phase, 
where there was progressive diminution in hemolytic activity at any increase 
above ionic strength 0.15 and marked diminution above 0.25. The most active 
system, that utilizing PNH cells and complement-depleted antiserum II, was 
less sensitive to changes in ionic strength, there being no decrease in activity 
in the cold phase at ionic strength 0.30, and decrease in the warm phase to 
slightly less than one-half the original activity at ionic strength 0.40. It is this 
reaction which does not require fresh serum in the cold phase. C.  ~.  HINZ,  JR.,  ~I.  E.  PICKEN,  AND  I.  H.  LEPOW  187 
E.  Divalent Cations.--Studies  on the  requirements  for divalent  cations  in 
the two phases of the reaction utilized  PNH erythrocytes with purified anti- 
body I  at a  level equivalent to 0.1  ml. of original serum. This antibody level 
required the presence of fresh serum in both the cold and warm phases of the 
reaction. 
In the presence of undiluted serum and an excess of complement, resin treat- 
ment of the reagents in both phases with the cation exchange resin  amberlite 
IRC-50 resulted in about a  50 per cent decrease in over-all hemolytic activity 
as reported previously (20). 
J  ,  J  , 
o 
o.6  f  o  (~)  o 
/ 
o 
0.5 
I-- 
¢0  0.4 
Z 
U.I 
a 
.j  0.3 
¢.) 
0.2 
0 
o  x 
OA F 
x 
I 
e.~--o 
/ 
/ 
(!) 
~  x__ x  --x 
/  ® 
I  l  I  I 
2  4  6  8  I0 
MINUTES 
FIG. 5.  Effect of time of incubation during the warm phase of the  Donath-Landsteiner 
reaction. 
Key: (1) PNH cells and purified antibody I; (2) Normal cells and complement-depleted 
antiserum II; (3) PNH cells and complement-depleted  antiserum II. 
Resin treatment in the cold phase alone had little effect, but resin treatment 
in  the warm phase reduced  hemolytic activity approximately one-half.  This 
was restored completely by addition of 10  -4 ~  Mg  ++, but was not affected by 
low levels of Ca  ~-, and was further inhibited at a concentration of 10  ~  M Ca  ++. 
The  effect of EDTA  was  more pronounced.  With  undiluted  fresh  serum, 
3  X  10  -8 •  Na3EDTA or Na2BaEDTA blocked completely the  initial  cold 
phase of the reaction. Na2MgEDTA inhibited partially, and Na~CaEDTA was 
without effect. On diluting fresh serum 1 to 4, Na3EDTA, Na~BaEDTA, and 
Na2MgEDTA  blocked  the  cold  phase  completely,  and  Na,CaEDTA  was 
without effect, indicating a requirement for Ca++ in the initial cold phase of the 
reaction. 
In  the  warm phase  of  the  reaction  with  the  usual  concentration  of fresh 
serum, 10  -~ M Na3EDTA and Na2BaEDTA blocked completely the hemolytic 188  IMMUNE  HUMAN  HEMOLYSIS.  I. 
reaction,  but  comparable  levels  of  Na2MgEDTA  and  Na2CaEDTA  were 
without effect. In each instance addition of equimolar Mg  ++ restored hemolytic 
activity. These  data indicate that Mg  ++ but  not  Ca  -H- was  required  in the 
warm phase. Data are presented in the subsequent  paper which indicate that 
Ctl acts in the cold phase, C'4 may interact in either the cold or warm phase, 
and C~2 and C~3 in the warm. The observations  reported here on the require- 
ment for Ca  -H- in the cold phase and Mg  ++ in the warm phase are consistent 
with published  observations  on the role of cations  in the sequential  action of 
the  components  of  complement  (2). 
DISCUSSION 
There have been many conflicting reports  concerning the properties  of the 
D-L antibody and the characteristics  of the hemolytic reaction.  A number of 
early investigators  (7,  8)  in  their  original  observations  demonstrated that 
hemolysis occurred even though fresh serum was not present in the initial cold 
phase.  Hoover and  Stone,  Moss,  and  Cooke  (4-6)  demonstrated that  fresh 
serum as a source of complement was required in the cold phase with the anti- 
bodies  they were studying. There have also been  differences concerning  the 
critical temperature and rate of the cold phase of the reaction. 
The present study confirms the surmise made originally by Mackenzie  (21) 
and repeated by Dacie (16) that many of the discrepancies previously observed 
may be related to characteristics  of the several constituents of the hemolytic 
system and to the kinetics  of the reaction. 
For example, the potency of antibodies varies, as indicated by the two sera 
studied here which differed strikingly in hemolytic titer against the same cells. 
The sensitivity of erythrocytes to hemolytic antibody varies  greatly as em- 
phasized  by the comparison  between  normal and  PNH  erythrocytes in the 
present studies, and by others in noting differences in the hemolysis of isologous 
and heterologous cells by D-L antibodies (22). The current observations clearly 
emphasize that the requirement for complement in both phases of the Donath- 
Landsteiner reaction is quantitative and not qualitative, depending upon the 
level  of antibody and sensitivity of erythrocytes. Under  any circumstances 
the presence  of complement  during the cold phase  resulted in markedly in- 
creased hemolysis. Although this effect of complement is especially marked in 
the  Donath-Landsteiner reaction,  it  is  not  unlike  earlier  observations  by 
Maurer  and  Talmage,  who  offered  evidence  indicating  increased  antigen- 
antibody interaction in the presence of non-immune serum (23). The antibody 
level  and  cell sensitivity also  influenced  the  critical  temperature and  rates 
of reaction. 
The selection of kinetic conditions  in the two phases  of the reaction  also 
influences profoundly the course of the reaction,  and there is little evidence in 
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For example, striking differences in the cold phase were noted in the present 
study between temperatures of 1  ° and 5°C., and as recorded here, the relative 
amounts of  antibody and  complement are  also  critical  factors.  Further,  in 
many studies the source of antibody was heated serum which may have an 
inhibitory effect on the initial stage of the reaction, as noted here when heated 
normal serum was added to the reaction mixture. 
It is apparent from a review of reports of the various D-L hemolysins which 
have been studied that there are other serologic properties than those considered 
here which differ from patient to patient. In some cases of luetic cold hemo- 
globlnuria, there have been moderately high titers of cold aggiufinins (3,  24, 
25),  although none have been as high as reported with cold hemoglobinuria 
due to cold agglutinins. In most patients the direct antiglobulin test is positive 
only immediately after chilling, but in a  few the direct antiglobulin test has 
been consistently positive  even in the absence of chilling  (26).  There  is  no 
reason to doubt that these patients had cold hemolysins of the D-L type. Some 
antibodies  have  been  reported  to  be  heat  labile  (6,  18,  19),  whereas  most 
others have been heat stable, variations which may have been due to inhibitory 
properties acquired by serum during heating or possibly to small but critical 
losses  of antibody during heating of low potency sera. These varied serologic 
characteristics are similar to the apparent variable nature of the serum protein 
abnormalities which occur in syphilis and to the great variation and lack of 
consistency of serologic tests for syphilis. 
It will be noted that in neither of the patients reported here was there a 
high titer of cold agglntinins, consistent with the conclusion that both anti- 
bodies were D-L biphasic cold hemolysins. Agglutination following the  cold 
phase was slight and the cells were easily resuspended, in contrast to the marked 
agglutinating properties  of  hemolytic amounts  of  isoantibodies  or  to  cold 
agglutinins. It is further noted that hemolysin activity was present in a fraction 
which contained little or none of the Kline antibody, corroborating observa- 
tions made many times previously (8,  27)  that the D-L antibody is distinct 
from the antibody responsible for the serologic tests for syphilis. 
Other observations reported here may also contribute to an understanding 
of  the  discrepant observations reported previously regarding  the  maximum 
temperature at which the cold phase of the reaction will proceed.  Although 
temperatures under 10°C. were required using normal cells, in confirmation of 
the observations of Mackenzie (20)  and Dacie,  erythrocyte sensitization oc- 
curred at higher temperatures when a  more sensitive system was used, i.e., 
PNH erythrocytes and the high titer non-luetic antiserum II. This is similar 
to the observation of Grafe in 1911 (28). 
The relatively low temperature at which hemolysis occurs after completion 
of the cold phase also may explain the previously observed monophasic hemol- 
ysis which has been observed to occur at 17°C.,  a temperature low enough to 190  IMMUNE  HUMAN  HEMOLYSIS.  I. 
result in reaction of antibody with cell and high enough to result in lysis by 
complement (9, 29). 
One objective of the present study was to establish conditions suitable for 
the study of the mechanism of action of human complement on human erythro- 
cytes, particularly related to a naturally occurring human disease. As pointed 
out, it was possible to adjust the concentration of the various reactants so that 
fresh serum was required in both the initial cold and final warm phases of tile 
reaction. It may be emphasized that despite all the variables which may influ- 
ence this biphasic system, it is similar to other immune hemolytic systems in 
requiring antibody, all four components of complement, and Ca  ++ and Mg++ 
for activity. The accompanying report offers evidence that C'I participates in 
the  cold phase  of the reaction  and  is  thus  responsible  for  the  initiation  of 
hemolytic complement activity as has been proposed previously (1,  30). 
SUMMARY 
The  Donath-Landsteiner  reaction  was  studied  using  low  and  high  titer 
antisera  and purified antibody,  normal  and  PNH  erythrocytes, and  human 
serum complement. 
The requirement for complement in both the cold and warm phases of the 
reaction depended upon the level of antibody used and the sensitivity of the 
cells  to  hemolytic  antibodies.  Complement  was  not  necessary  in  the  cold 
phase using PNH cells and a potent source of antibody, but complement was 
required to be present at some stage if hemolysis were to occur. 
Optimal  conditions for the cold phase were at  1°C.  for 30 minutes at pH 
7.4.  Ca  ~- ions were required. Hemolysis in the warm phase occurred within 
one minute, was optimal at 32°C., and required Mg  ++. 
The  relation  of  these  observations  to  previous  reports  is  discussed  with 
respect to discrepant observations on the  nature  of the  Donath-Landsteiner 
reaction. 
These studies would not have been possible without the cooperation of Dr. Robert C. 
Griggs, Cleveland Metropolitan General Hospital, Cleveland, Ohio, who made available 
large amounts of serum from case I; and Dr. George O. Clif[ord, Wayne State University 
College of Medicine, Detroit, Michigan, who supplied serum from case II. 
The authors are also indebted to Mr. Karl Meinhardt who performed the serologic tests 
for syphilis. 
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